CB2 Insights’ CEO Pradyum Sekar recently sat down with Barrington Miller to discuss the importance of medically validated cannabis data (3:45), the challenge of breaking down barriers with physicians (9:45), and the impact of big pharma on medical cannabis (13:30). Listen until the end to hear about Prad’s experience around launching the company, pivoting the business (hint – vertical integration!), and their recent launch on the CSE – Canadian Securities Exchange.
